ftInvstr
PFIZER · Healthcare ₹4600.0 -0.9% Mkt Cap ₹21052 Cr fair

PFIZER

Healthcare Drug Manufacturers - General
₹4600.0
-0.9% today · 30d -6.18%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for PFIZER. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹653 Cr
+8.31% YoY
NET PROFIT
₹204 Cr
+6.63% YoY
OPM
41.89%
+0.53pp YoY
EPS
₹44.69
PE 28.57
Intrinsic value · DCF ₹4736.51 · Margin of safety +3.0% (fair) · FCF yield 4.48%
◇ Sector Position
PEERPEROCE %
PFIZER28.57
GLAXO46.8657.97
RUBICON101.0127.36
MARKSANS28.5420.53
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
64
SCORE / 100
Overall
6-axis composite of the sections below.
Performance NEUTRAL 40
Valuation REASONABLE 60
Growth STEADY 53
Profitability HIGH 100
Technicals WEAK 38
Risk LOW 90
Key Stats
TTM PE
28.57
P/B
5.0
52W HIGH
₹5787.0
OFF HIGH
-20.51%
DIV YIELD
1.63%
MKT CAP
₹21052 Cr
◉ Active Signals
MACDBearish-36.2231
RSI(14)Bearish36.49
Near 52W LowBearish5.5
Street Consensus
4 analysts
₹6658.5
mean target
Low ₹5815.0Now ₹4600.0High ₹7500.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PFIZER and at what entry.

Sign up freeSign in